PT-141 (Bremelanotide) — 6-pack
Intimate science. An open conversation.
PT-141, also called bremelanotide, acts at melanocortin receptors and appears in research on sexual desire. It’s a specific scientific conversation, and one we can have without the awkward whispering. Let’s start with what the name actually means. This pack contains 6 vials of the same listed product.
$750.60 AUD
- Pack quantity
- 6 items
- Presentation
- Vial
- The details
- Specifications pending confirmation
Choose your pack
Delivered every month · 20% off each recurring order.
Preview bag only · No orders or payments
Let’s get acquainted.
The useful bits. The finer points.
The questions you were about to Google.
The useful bits, up front.
- Also known as bremelanotide. Two names used for the same active molecule.
- Melanocortin receptor activity. A receptor-based mechanism explored in pharmacology and sexual-health research.
- A defined clinical context. A particular US prescription medicine has a specific indication; that is not a general promise for everyone.
A little more of the story.
Desire is personal, and the science deserves a little space from the stereotypes. Research on bremelanotide includes a specific prescription medicine for certain premenopausal women with acquired, generalised hypoactive sexual desire disorder. That context helps explain the interest in the molecule. It also keeps the conversation grounded in the people and product actually studied, without suggesting there’s one right way to feel.
What’s in the 6-pack?
6 × PT-141 (Bremelanotide) — proposed 10 mg per vial. The 6-pack brings the same listed product together in one selection. The compound story stays the same across every size; only the quantity changes.
Pack quantity counts items, not doses or a recommended course. The proposed amount is total vial content, not a concentration or suggested dose.
Good to know.
This proposed vial is not identified as Vyleesi or verified as equivalent to it. The medicine’s indication does not establish this product’s safety, suitability or effectiveness. Product and batch specifications remain pending.
The finer points.
| Product | PT-141 (Bremelanotide) |
|---|---|
| Pack contents | 6 vials |
| Presentation | Vial |
| Proposed content per vial | 10 mg — supplier confirmation pending |
| Formulation and fill details | Product-specific confirmation pending |
| Batch, manufacturer and expiry | Current-batch details pending |
| Identity, content and purity | Current-batch verification pending |
| Storage and stability | Product-specific information pending |
| Sterility and endotoxin | Not verified |
Are PT-141 and bremelanotide different ingredients?
PT-141 is another name for bremelanotide. A name alone does not identify a verified finished medicine.
Is it a general sexual-performance product?
The cited medicine evidence concerns a defined condition and population. It does not support a general performance promise.
Explore the source material.
These references describe research or specific medicines. They do not verify the contents or performance of this catalogue product.